New leukemia drug could replace invasive chemical therapy treatment
By Catholic Online (NEWS CONSORTIUM)
6/4/2014 (2 years ago)
Catholic Online (www.catholic.org)
An Australian doctor suggests that the anti-leukemia drug Ibrutinib could end traditional chemotherapy treatments forever. Trial tests have given researchers renewed hope in the fight against leukemia.
Ibruntinib is far less invasive than traditional forms of radiation.
LOS ANGELES, CA (Catholic Online) - Results of a trial on 391 patients showed the drug Ibrutinib gave patients fighting a type of slow growing blood cancer called chronic lymphocytic leukemia. The new drug gave patients a 90 percent chance of survival, eight higher than the 81 percent who survive on chemotherapy treatment alone.
Ibruntinib is far less invasive than traditional forms of radiation. The drug is being sought as an alternative for patients whose cancer cells have built up a resistance to chemotherapy. Results from the trial also showed that four out of every 10 patients entered remission within a year in contrast to four in 100 on a traditional course of radiation.
"We might not need chemotherapy at all," Dr. Con Tam of Melbourne's Peter MacCallum Cancer Center says. He's confident that Ibrutinib will eventually replace chemotherapy as the main treatment for leukemia patients.
Patients on the international trial responded quicker to the drug than chemotherapy and showed fewer side effects, according to Dr. Tam. Also encouraging was that patients who do not respond to, or have a resistance to chemotherapy treatments, now have an alternative.
"These resistant patients have no other treatment option," the co-author of a New England Journal of Medicine report said. "This pill works extremely well when chemotherapy stops working."
The drug disables an enzyme crucial for leukemia's survival. Ibrutinib is currently being fast tracked for approval in the US and it could be just a year before Australians have access to it.
One of the rarest forms of cancer, CCL is the most common type of leukemia. The older you are, the higher the chance you have of developing it. Almost 80 percent of all new cases are diagnosed in people over the age of 60.
Occurring more frequently in men than women, symptoms develop slowly, many people don't show symptoms in its early stages.
Copyright 2017 - Distributed by THE CALIFORNIA NETWORK
Pope Francis Prayer Intentions for FEBRUARY 2017
Comfort for the Afflicted. That all those who are afflicted, especially the poor, refugees, and marginalized, may find welcome and comfort in our communities.
"God doesn't ask us to be super-heroes," assured Cardinal Pietro Parolin, on February 11, 2017, the 25th World Day of the Sick. ... continue reading
(Vatican Radio) Pope Francis on Friday spoke about the situations of "light and shadow" in the healthcare sector, thanking God for ... continue reading
Researchers have uncovered the grave of an unusual leprosy patient from medieval England. His bones tell a story that could help rewrite ... continue reading
As we approach both Christmas and the New Year, many of us like to take stock of the past year and to make concrete plans for the next. ... continue reading
For decades, doctors have warned that germs are evolving faster than we can produce new antibiotics to kill them. Eventually our ... continue reading
by Catholic Online
- Daily Readings for Monday, February 20, 2017
- Pope Francis shares words of wisdom
- Daily Reading for Wednesday, February 22nd, 2017 HD Video
- Catholics Should Read, Pray, Live and Love the Bible as the Word of God
- St. Wulfric: Saint of the Day for Monday, February 20, 2017
- Massive storm threatens to flood more than just the Oroville Dam HD Video
- What is the Pope doing in California?
- Daily Reading for Tuesday, February 21st, 2017 HD
- Daily Reading for Monday, February 20th, 2017 HD
- Daily Reading for Sunday, February 19th, 2017 HD
- Daily Reading for Saturday, February 18th, 2017 HD
Copyright 2017 Catholic Online. All materials contained on this site, whether written, audible or visual are the exclusive property of Catholic Online and are protected under U.S. and International copyright laws, © Copyright 2017 Catholic Online. Any unauthorized use, without prior written consent of Catholic Online is strictly forbidden and prohibited.